HomeCompareMGRM vs SPHD

MGRM vs SPHD: Dividend Comparison 2026

MGRM yields 33.33% · SPHD yields 4.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGRM wins by $133.6K in total portfolio value
10 years
MGRM
MGRM
● Live price
33.33%
Share price
$6.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$160.1K
Annual income
$23,203.52
Full MGRM calculator →
SPHD
SPHD
● Live price
4.33%
Share price
$49.34
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$571.32
Full SPHD calculator →

Portfolio growth — MGRM vs SPHD

📍 MGRM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGRMSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGRM + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MGRM pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGRM
Annual income on $10K today (after 15% tax)
$2,833.33/yr
After 10yr DRIP, annual income (after tax)
$19,722.99/yr
SPHD
Annual income on $10K today (after 15% tax)
$367.92/yr
After 10yr DRIP, annual income (after tax)
$485.62/yr
At 15% tax rate, MGRM beats the other by $19,237.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGRM + SPHD for your $10,000?

MGRM: 50%SPHD: 50%
100% SPHD50/50100% MGRM
Portfolio after 10yr
$93.3K
Annual income
$11,887.42/yr
Blended yield
12.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MGRM right now

MGRM
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$5.40
-10.0% upside vs current
Range: $5.40 — $5.40
Altman Z
12.6
Piotroski
2/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGRM buys
0
SPHD buys
0
No recent congressional trades found for MGRM or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGRMSPHD
Forward yield33.33%4.33%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$160.1K$26.5K
Annual income after 10y$23,203.52$571.32
Total dividends collected$113.6K$5.1K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MGRM vs SPHD ($10,000, DRIP)

YearMGRM PortfolioMGRM Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$14,033$3,333.33$11,133$432.85+$2.9KMGRM
2$19,387$4,371.75$12,363$450.36+$7.0KMGRM
3$26,389$5,644.57$13,695$467.39+$12.7KMGRM
4$35,417$7,180.46$15,138$483.90+$20.3KMGRM
5$46,902$9,006.44$16,697$499.88+$30.2KMGRM
6$61,333$11,146.93$18,382$515.31+$43.0KMGRM
7$79,249$13,622.82$20,198$530.17+$59.1KMGRM
8$101,247$16,450.69$22,157$544.46+$79.1KMGRM
9$127,976$19,642.17$24,266$558.18+$103.7KMGRM
10$160,138$23,203.52$26,536$571.32+$133.6KMGRM

MGRM vs SPHD: Complete Analysis 2026

MGRMStock

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Full MGRM Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this MGRM vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGRM vs SCHDMGRM vs JEPIMGRM vs OMGRM vs KOMGRM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.